RhemaStem, a biotech company specialising in the research and development of innovative drugs for colorectal cancer and other solid cancers. We provide an advanced and unique platform technology to address critical shortcomings in existing methods of isolation and production of tumour and normal stem cells for drug discovery and development.

Our goal? To cure colorectal cancer and other solid cancers with our unique expertise and skills in the field of cancer and normal stem cells – an approach we champion with unwavering conviction.

RhemaStem also offers consulting services in the area of solid cancer stem cells, encompassing colon, lung, breast, prostate, ovary, brain, circulating blood cells, and other cancers.